Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

Early NeoALTTO Results Show Promise

Early results from the Neo-ALTTO show that two medicines used together before surgery substantially increased response rates in HER2 positive early-stage breast cancer.

Being too fat raises risk of deadly breast cancer

CHICAGO (Reuters) - Scientists know that being overweight increases the risk of breast cancers fed by estrogen, but being too fat may also increase the risk of triple-negative breast cancers, a less common and far more deadly type, U.S. researchers said on Tuesday.

U.S. breast cancer rates have stopped falling

CHICAGO (Reuters) - Breast cancer rates among U.S. white women have stopped falling, U.S. researchers said on Monday, suggesting that the fallout from a 2002 study linking hormone replacement therapy to breast cancer was short lived.

Breast cancer screening less accurate in survivors

NEW YORK (Reuters Health) - Screening mammography is less accurate at spotting breast cancer if a woman has had the disease before, according to a new government-funded study.

Starting HRT early raises breast cancer risk: study

WASHINGTON (Reuters) - Women who start hormone replacement therapy (HRT) as they begin to go through menopause have a higher risk of breast cancer than women who start taking the drugs later, researchers reported on Friday.

Test for Tamoxifen Effectiveness Falls Short

Results from two studies presented at the San Antonio Breast Cancer Symposium (SABCS) show no association between CYP2D6 levels and tamoxifen effectiveness in postmenopausal women.

Radiation may increase long-term heart risks

NEW YORK (Reuters Health) - Women treated for breast cancer with radiation therapy are more likely to die from heart disease 20 years or more down the line than women who don't get radiation, according to a new study.

Company Requests Hearing for Avastin

Roche/Genentech, maker of Avastin (bevacizumab), has requested a hearing before the U.S. Food and Drug Administration to appeal the agency’s December 2010 decision to withdraw approval of bevacizumab as a treatment for metastatic breast cancer.

Avastin raises heart failure risk in breast cancer

CHICAGO (Reuters) - Women with advanced breast cancer who were treated with Roche's Avastin were more likely to develop heart failure than other women, according to an analysis released on Tuesday that raised more concerns about the already troubled drug.

Family history not the sole risk for breast cancer

NEW YORK (Reuters Health) - A new study reconfirms something often forgotten by women and sometimes even by doctors: just because breast cancer has not struck a family before does not mean family members are safe from the disease.